Presentations Medicenna Therapeutics Corp. - Corporate Presentation December 2024 Sachs 10th Annual Oncology Innovation Forum Presentation Clinical Update from Phase 1/2 ABILITY Study National Brain Tumor Society's Research Round Table Presentation Past Events October 24 - October 25, 2020 Emergence of Novel Long-acting Mono- and Bi-specific IL-2/IL-13 Superkines as Potent Immune Modulators Go to October 24 - October 25, 2020 MDNA55, a Locally Administered IL4 Guided Toxin for Targeted Treatment of Recurrent Glioblastoma Shows Long Term Survival Benefit Go to October 1, 2020 at 12:30 PM EDT Virtual Gravitas Healthcare Investor Day Go to September 30, 2020 at 10:00 AM EDT Medicenna Annual and Special Meeting Go to September 22, 2020 at 2:30 PM EDT Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (virtual) Go to September 16, 2020 at 10:30 AM EDT H.C. Wainwright 22nd Annual Global Investment Conference 2020 (virtual) Go to Pagination First page « first Previous page ‹ previous … Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Current page 12 Page 13 Page 14 Next page next › Last page last »
October 24 - October 25, 2020 Emergence of Novel Long-acting Mono- and Bi-specific IL-2/IL-13 Superkines as Potent Immune Modulators Go to
October 24 - October 25, 2020 MDNA55, a Locally Administered IL4 Guided Toxin for Targeted Treatment of Recurrent Glioblastoma Shows Long Term Survival Benefit Go to
September 22, 2020 at 2:30 PM EDT Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (virtual) Go to
September 16, 2020 at 10:30 AM EDT H.C. Wainwright 22nd Annual Global Investment Conference 2020 (virtual) Go to
